Skip to main content
. 2020 Aug 3;20:59. doi: 10.1186/s12873-020-00344-9

Table 2.

Additional patient characteristics of included (pre)syncope patients

Arrival by ambulance, n (%) 71 (71.0)
Cardiovascular history, n (%) 54 (53.5)
 • Hypertension 40 (39.6)
 • Myocardial infarction 14 (13.9)
 • Heart failure 4 (4.0)
 • Rhythm disorders (AF, VT) 15 (14.9)
 • Pacemaker/ICD 5 (5.0)
 • Peripheral vascular disease 9 (8.9)
 • Thrombosis 8 (7.9)
Parkinson’s disease 3 (3.0)
Diabetes mellitus 12 (11.9)
History of syncope 63 (62.4)
Antihypertensive medication, n (%) 46 (45.5)
 • B-blocker 25 (24.8)
 • ACE inhibitor or angiotensin II blocker 31 (30.7)
 • Calcium antagonist 9 (8.9)
 • Diuretics 21 (20.8)
 • ≥2 antihypertensive drugs 29 (28.7)
Antidepressants 8 (7.9)
Polypharmacy (≥5) 40 (39.6)
ECG performed 101 (100.0)
Orthostatic BP test performed by initial treating physicians 40 (39.6)
Additional tests performed in the ED, n (%)
 • Laboratory tests 97 (96.0)
 • Chest x-ray 18 (17.8)
 • Computed tomography (head or chest) 14 (13.8)
Consultation of another specialist in the ED, n (%) 33 (32.7)
 • One specialist 27 (26.7)
 • Two specialists 6 (5.9)
Department of admission, n (%)
 • Cardiology 5 (31.2)
 • Internal Medicine 10 (62.5)
 • Neurology 1 (6.3)
Median number of days hospitalised (range) 3.13 (1-13)

AF atrial fibrillation, BP blood pressure, ED Emergency Department, ICD implantable cardioverter-defibrillator, VT ventricular tachycardia